Adaptive Biotechnologies Corp SEC filings ADPT

Adaptive Biotechnologies Corp has 832 filings in SEC EDGAR's recent list, going back to Dec 28, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Adaptive Biotechnologies Corp SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Results of operations, Officer or director change
Jul 29, 2026 Jul 24, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
Jun 22, 2026 Jun 15, 2026
8-K Current report
Other events
Jun 15, 2026 Jun 15, 2026
8-K Current report
Shareholder vote results
Jun 9, 2026 Jun 5, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
8-K Current report
Results of operations
Feb 5, 2026 Feb 5, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Other events
Dec 30, 2025 Dec 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Agreement ended
Aug 18, 2025 Aug 13, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Shareholder vote results
Jun 12, 2025 Jun 10, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
8-K Current report
Results of operations
Feb 11, 2025 Feb 11, 2025
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Shareholder vote results, Other events
Jun 11, 2024 Jun 7, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
8-K Current report
Officer or director change
Apr 9, 2024 Apr 4, 2024
8-K Current report
Results of operations
Apr 5, 2024 Apr 2, 2024
8-K Current report
Officer or director change
Apr 2, 2024 Apr 1, 2024
8-K Current report
Results of operations
Feb 14, 2024 Feb 14, 2024
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Officer or director change
Sep 1, 2023 Sep 1, 2023
8-K Current report
Results of operations, Officer or director change
Aug 2, 2023 Jul 28, 2023
8-K Current report
Listing notice
Jul 3, 2023 Jun 26, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2023 Jun 9, 2023
8-K Current report
Regulation FD disclosure, Other events
May 9, 2023 May 9, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
8-K Current report
Officer or director change
Apr 11, 2023 Apr 7, 2023
8-K Current report
Results of operations
Feb 14, 2023 Feb 14, 2023
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Material agreement, New debt, Other events
Sep 12, 2022 Sep 12, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Shareholder vote results
Jun 14, 2022 Jun 10, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
8-K Current report
Other events
Mar 25, 2022 Mar 25, 2022
8-K Current report
Officer or director change
Mar 11, 2022 Mar 9, 2022
8-K Current report
Results of operations, Officer or director change
Feb 15, 2022 Feb 15, 2022
8-K Current report
Results of operations, Officer or director change
Jan 10, 2022 Jan 4, 2022
8-K Current report
Results of operations, Officer or director change
Nov 3, 2021 Oct 28, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
8-K Current report
Shareholder vote results
Jun 14, 2021 Jun 11, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 17, 2021 Mar 16, 2021
8-K Current report
Officer or director change
Mar 5, 2021 Mar 4, 2021
8-K Current report
Regulation FD disclosure, Other events
Mar 2, 2021 Mar 2, 2021
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-K Current report
Officer or director change
Jan 27, 2021 Jan 21, 2021
8-K Current report
Other events
Nov 12, 2020 Nov 11, 2020
8-K Current report
Results of operations
Nov 10, 2020 Nov 10, 2020
8-K Current report
Officer or director change
Oct 16, 2020 Oct 9, 2020
8-K Current report
Other events
Aug 21, 2020 Aug 21, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K Current report
Material agreement, Results of operations, Other events
Jul 16, 2020 Jul 14, 2020
8-K Current report
Officer or director change
Jun 26, 2020 Jun 25, 2020
8-K Current report
Shareholder vote results
Jun 16, 2020 Jun 12, 2020
8-K Current report
Results of operations
May 12, 2020 May 12, 2020
8-K Current report
Regulation FD disclosure
May 5, 2020 May 5, 2020
8-K Current report
Regulation FD disclosure
Mar 20, 2020 Mar 20, 2020
8-K Current report
Results of operations
Feb 26, 2020 Feb 26, 2020
8-K Current report
Officer or director change
Feb 18, 2020 Feb 13, 2020
8-K/A Amended current report Jan 27, 2020 Jan 21, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Jan 24, 2020 Jan 21, 2020
8-K Current report
Regulation FD disclosure
Jan 8, 2020 Jan 8, 2020
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
8-K Current report
Material agreement, Regulation FD disclosure
Sep 24, 2019 Sep 24, 2019
8-K Current report
Results of operations
Aug 13, 2019 Aug 13, 2019
8-K Current report
Material agreement, Regulation FD disclosure
Aug 7, 2019 Aug 2, 2019
8-K Current report
Regulation FD disclosure
Aug 2, 2019 Jul 31, 2019
8-K Current report
Bylaw or fiscal year change, Other events
Jul 1, 2019 Jun 26, 2019

Showing 72 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ADPT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
WA
Headquarters
Seattle, WA
SEC filer status
Large accelerated filer
SEC CIK
1478320
Former names
Adaptive TCR Corp (until Jun 2, 2011)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.